Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs

Prevalence of use and acute toxicity associated with the use of NBOMe drugs

(2015) David M. Wood et al.   CLINICAL TOXICOLOGY

Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations

(2014) Fridtjof Heyerdahl et al.   CLINICAL TOXICOLOGY

The European Drug Emergencies Network (Euro-DEN)

(2014) D. M. Wood et al.   CLINICAL TOXICOLOGY

Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP)

(2012) David M. Wood et al.   CLINICAL TOXICOLOGY

Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity

(2012) David M. Wood et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Novel Psychoactive Substances

(2012) David M. Wood et al.   THERAPEUTIC DRUG MONITORING

The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)

(2011) Paul I. Dargan et al.   Drug Testing and Analysis